Deputy Head of Division (Research)
The Deputy Head of Division (Research) provides leadership support for the Head of Division in areas related to research, including representing the Division’s interests within the University, with external funders and within the National Health Service.
- Leadership for the development of divisional research strategy
- Facilitating the cross-departmental and cross-divisional strategies in support of research themes and platform technologies
- Developing strategic partnerships with universities and other organisations
- Evaluating of the Division’s research and its impact; including the REF exercises
- Working closely with the Directors of the two Oxford Biomedical Research Centres to ensure their success
- Providing strategic leadership for researcher development and researcher career pathway activities
- Leadership, coordination and support for large-scale, cross-departmental and cross-divisional strategic bids and initiatives
- Overseeing the strategy for the use of internal research funds
- Supporting the provision of a research environment (space, equipment, staff) of the highest quality to enable the recruitment and retention of the very best researchers and students
- Ensuring that there is high-quality research support and research management available to all researchers (through the work of the Divisional Research Team and Research Services)
As the Oxford University Hospitals’ Director of Research and Development, Professor Channon has extensive responsibilities for R&D matters within the Trust including the University/OUH Biomedical Research Centre, the relevant clinical research metrics and management of the R&D interface with the University.
Exercise and cardiovascular health: new routes to reap more rewards.
Channon KM., (2020), Cardiovasc Res, 116, e56 - e58
Hyper-acute cardiovascular magnetic resonance T1 mapping predicts infarct characteristics in patients with ST elevation myocardial infarction.
Alkhalil M. et al, (2020), J Cardiovasc Magn Reson, 22, 3 - 3
Pressure-bounded Coronary Flow Reserve to Assess the Extent of Microvascular Dysfunction in Patients With ST-elevation Acute Myocardial Infarction
Scarsini R. et al, (2019), EuroIntervention
The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade.
Kalla M. et al, (2019), Eur Heart J
Association of troponin level and age with mortality in 250 000 patients: cohort study across five UK acute care centres.
Kaura A. et al, (2019), BMJ (Clinical research ed.), 367, l6055 - l6055